Emergent BioSolutions (EBS) Goodwill & Intangibles (2016 - 2025)
Historic Goodwill & Intangibles for Emergent BioSolutions (EBS) over the last 16 years, with Q3 2025 value amounting to $452.7 million.
- Emergent BioSolutions' Goodwill & Intangibles fell 1257.24% to $452.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $452.7 million, marking a year-over-year decrease of 1257.24%. This contributed to the annual value of $501.5 million for FY2024, which is 1148.96% down from last year.
- According to the latest figures from Q3 2025, Emergent BioSolutions' Goodwill & Intangibles is $452.7 million, which was down 1257.24% from $469.0 million recorded in Q2 2025.
- Over the past 5 years, Emergent BioSolutions' Goodwill & Intangibles peaked at $949.8 million during Q3 2022, and registered a low of $452.7 million during Q3 2025.
- Over the past 5 years, Emergent BioSolutions' median Goodwill & Intangibles value was $801.5 million (recorded in 2022), while the average stood at $702.2 million.
- In the last 5 years, Emergent BioSolutions' Goodwill & Intangibles surged by 1416.52% in 2022 and then plummeted by 4016.9% in 2023.
- Emergent BioSolutions' Goodwill & Intangibles (Quarter) stood at $829.5 million in 2021, then grew by 14.17% to $947.0 million in 2022, then crashed by 40.17% to $566.6 million in 2023, then fell by 11.49% to $501.5 million in 2024, then fell by 9.73% to $452.7 million in 2025.
- Its Goodwill & Intangibles stands at $452.7 million for Q3 2025, versus $469.0 million for Q2 2025 and $485.2 million for Q1 2025.